期刊文献+

肿瘤防治过程中出现的晕轮效应

The halo effect in tumor treatment
下载PDF
导出
摘要 在中医或放化疗、手术防治肿瘤过程中,出现的一过性肿块增大或淋巴结增多的现象,而这种现象有时预示着肿瘤治疗有效,是人体抗癌的一种特殊反应,借用心理学术语,称为晕轮效应。判断晕轮效应的依据包括哲学依据、形神医学以及血常规。目的是避免定势思维,误将好转的迹象当成恶化,中断或改变既定的有效治疗方案,从而延缓或错失治疗时机,造成不良后果。晕轮效应的提出,为肿瘤的防治提供了新思路和新视角,从而加深对肿瘤的认识,有利于提高肿瘤的治愈率。 In the process of treating tumor with traditional Chinese medicine, chemoradiation or medical operation, the tumor will expand or the lymph nodes will become swollen evanescently. This is a special effective reaction of human resisting caner, which is named the halo effect in psychological terms. To determine whether it is the halo effect is based on philosophical foundation, body-vital energy theory of traditional Chinese medicine, and blood routine examination. The correct judgment of the halo effect is to avoid the interruption of the effective therapy due to the fixed pattern of thinking and to grasp the favorable opportunity in tumor treatment. The conception of the halo effect in the treatment of tumors may provide a new perspective to the medication and help to further improve the cure rate.
作者 罗安明 江建清 李世敏 万金阳 李忠 LUO Anming;JIANG Jianqing;LI Shimin;WAN Jinyang;L(Traditional Chinese Medicine Hospital of Xinzhou District, Wuhan 430400, China;Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine, Beijing 100700, China)
出处 《医学争鸣》 CAS 2018年第3期12-14,18,共4页 Negative
关键词 肿瘤 晕轮效应 哲学 形神合一 血常规 tumor halo effect philosophy unity of body and vital energy blood routine examination
  • 相关文献

参考文献5

二级参考文献18

  • 1门剑龙,徐凤华,华维.红细胞MCV RDW值鉴别贫血的临床价值[J].临床检验杂志,1995,13(5):241-242. 被引量:43
  • 2郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,1993.70.
  • 3Worht Heallh Organization.WHO handbook for reporling results of cancer treatment:WHO offset puldicalion number 48 Geneva:WHO,1979.
  • 4Duffaud F,Therasse P.New guidelines to evaluate the response to treatment in solid tumors [ J ].Bull Cancer,2000,87(12):881-886.
  • 5Yates JW,Chalmer B,McKegney FP:Evaluation of patients with advanced cancer using the Karnofsky performance slatus [ J ].Cancer,1980,45(8):2220-2224.
  • 6Mor V,I,aliberte L,Morris.IN,Wiemann M:The Karnofsky performance status scale.An examination of its reliability and validity in a research setting [ J ].Cancer,1984,53(9):2002-2007.
  • 7Llovet JM,Bru C,Bruix J.Prognosis of hepatocellular carcinoma:the BCLC Staging Classification [ J ].Semin Liver Dis,1999,19:329-338.
  • 8Sorensen JB,Klee M,Palshof T,et al.(1993)Performanee status assessment in cancer patients:An inter-observer variability study [J ].BrJ Cancer,1993,67(4):773-775.
  • 9Durand F,Valla D.Assessment of the prognosis of cirrhusis:Child-Pugh versus MELD [ J ].J Hepalol 2005,42(Suppl):S100-S107.
  • 10Dr. Harvey I. Pass MD,Karen Kranda RN,Barbara K. Temeck MD,Irwin Feuerstein MD,Seth M. Steinberg PhD. Surgically debulked malignant pleural mesothelioma: Results and prognostic factors[J] 1997,Annals of Surgical Oncology(3):215~222

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部